Signaling pathway for radiation-induced apoptosis in the lymphoblasts from neuronopathic (type A) and non-neuronopathic (type B) forms of Niemann–Pick disease

[1]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[2]  J. Jaffrezou,et al.  Lysosomal sphingomyelinase is not solicited for apoptosis signaling , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  C. Devlin,et al.  Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function. , 2000, Human molecular genetics.

[4]  E. Kolodny.  Niemann-Pick disease. , 2000, Current opinion in hematology.

[5]  Y. Hannun,et al.  The role of ceramide in cell signaling. , 1998, Biochimica et biophysica acta.

[6]  Y. Hirabayashi,et al.  Ceramide and Its Interconvertible Metabolite Sphingosine Function as Indispensable Lipid Factors Involved in Survival and Dendritic Differentiation of Cerebellar Purkinje Cells , 1998, Journal of neurochemistry.

[7]  K. Higaki,et al.  [Niemann-Pick disease [type A and B] (acid sphingomyelinase deficiencies)]. , 1998, Ryoikibetsu shokogun shirizu.

[8]  Obeid,et al.  Sphingomyelinases in cell regulation. , 1997, Seminars in cell & developmental biology.

[9]  A. Futerman,et al.  Distinct Roles for Ceramide and Glucosylceramide at Different Stages of Neuronal Growth , 1997, The Journal of Neuroscience.

[10]  T. Tokudome,et al.  Heterogeneity of liver disorder in type B Niemann-Pick disease. , 1997, Human pathology.

[11]  Y. Hannun.  Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.

[12]  Seamus J. Martin,et al.  Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis , 1996, Cell.

[13]  D. Perl,et al.  Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease , 1995, Nature Genetics.

[14]  R. Salvayre,et al.  Accurate Differentiation of Neuronopathic and Nonneuronopathic Forms of Niemann‐Pick Disease by Evaluation of the Effective Residual Lysosomal Sphingomyelinase Activity in Intact Cells , 1994, Journal of neurochemistry.

[15]  R. Desnick,et al.  Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms. , 1992, The Journal of biological chemistry.

[16]  R. Desnick,et al.  Identification of a missense mutation (S436R) in the acid sphingomyelinase gene from a Japanese patient with type B Niemann–Pick disease , 1992, Human mutation.

[17]  S. Chatterjee,et al.  Purification of neutral sphingomyelinase from human urine. , 1991, Methods in enzymology.

[18]  A. Bielawska,et al.  Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. , 1990, The Journal of biological chemistry.

[19]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .

[20]  Y. Miura,et al.  Transitory type of sphingomyelinase deficient Niemann-Pick disease: clinical and morphological studies and follow-up of two sisters. , 1987, The Tohoku journal of experimental medicine.

[21]  R. Salvayre,et al.  Sphingomyelinases and Niemann-Pick disease. , 1986, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[22]  J. Cohen,et al.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.